IP Library Granted Patent US 10,219,895
Granted Patent B2
US 10,219,895 · App. 14/438,142 · Granted Mar 5, 2019

Nanofiber-based graft for heart valve replacement and methods of using the same

Inventors: William D. Wagner (Clemmons, NC); Nicole Levi (Winston-Salem, NC); Rui Wang (Winston-Salem, NC); Louis C. Argenta (Winston-Salem, NC); Michael J. Morykwas (Winston-Salem, NC)
Assignee: WAKE FOREST UNIVERSITY HEALTH SCIENCES
A61F2/2412A61F2/2415A61F2/82A61K9/70A61L27/26A61L27/54A61L27/56C08J9/0061C08L89/00C08L89/06A61L2300/414A61L2400/12A61L2430/20C08J2389/00C08J2389/06C08J2467/02C08J2489/00C08J2489/06C08L2201/06C08L2203/02C08L2203/12C08L2205/02C08L2205/03Y10T428/298
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,219,895
App. No.
14/438,142
Granted
Mar 5, 2019
Kind
B2
Abstract

Nanofiber-based biomaterials containing fibroin for wound repair and tissue replacement and, more particularly, heart valve replacement.

Claims (42)

1. A porous electrospun graft material configured to replace biological tissue, the electrospun graft material comprising a collagen, a fibroin, and a hemocompatible synthetic elastomer,

wherein the hemocompatible synthetic elastomer is a polyglycerol derivative ester comprising a polycarboxylic acid, and

wherein collagen comprises 45 wt. % of the total composition weight, fibroin comprises 45 wt. % of the total composition weight, and the polyglycerol derivative ester comprising a polycarboxylic acid comprises 10 wt. % of the total composition weight.

2. The porous electrospun graft material according to claim 1 , wherein the biological tissue is heart tissue.

3. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has the shape of a heart valve.

4. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has the shape of an aortic heart valve.

5. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has the shape of a stent.

6. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has a percentage weight loss of no more than 0.3% per week over a 30 week period incubated at 37° C. in phosphate buffered saline (PBS) containing 0.1% sodium azide, with percentage weight loss calculated according to the formula weight loss (%)=W l /W i ×100%, where W i is the initial weight and W l is the weight loss.

7. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material is structurally and mechanically similar to native tissue.

8. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material is structurally and mechanically similar to native heart valve tissue.

9. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material is configured to promote cell adherence and proliferation.

10. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material is resorbable.

11. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material comprises a porous network of interconnected fibers effective to facilitate nutrient transport and cell signaling.

12. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material comprises a sheet material.

13. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material is sufficiently porous to facilitate cell adhesion, nutrient transport and signal transmission.

14. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material comprises a fibrous structure.

15. The porous electrospun graft material according to claim 14 , wherein the fibers of the fibrous structure have a diameter of 2712 to 3192 nm.

16. The porous electrospun graft material according to claim 14 , wherein the fibers of the fibrous structure have a diameter of 2900 to 3000 nm.

17. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material comprises a porous network of interconnected fibers, wherein the porous network is 100 to 300 μm thick.

18. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has a porosity of 67% to 80%, with the porosity calculated as

ɛ

=

V

liq

V

liq

+

V

MAT

,

where V liq is volume of intruded water and V MAT is the volume of the electrospun graft material.

19. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has an elastic modulus from 3.98 to 4.24 Mpa, with the modulus calculated using a 500 N load cell to perform uniaxial tensile tests after hydration of the porous electrospun graft material in 100 ml DDH 2 O for 10 minutes at an elongation rate of 10 mm/min.

20. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has a stress value of 1.40 to 1.50 Mpa, with the stress value calculated using a 500 N load cell to perform uniaxial tensile tests after hydration of the porous electrospun graft material in 100 ml DDH 2 O for 10 minutes at an elongation rate of 10 mm/min.

21. The porous electrospun graft material according to claim 1 , wherein the porous electrospun graft material has a strain value of 0.40 to 0.42 mm/mm, with the strain value calculated using a 500 N load cell to perform uniaxial tensile tests after hydration of the porous electrospun graft material in 100 ml DDH 2 O for 10 minutes at an elongation rate of 10 mm/min.

22. The porous electrospun graft material according to claim 1 , wherein the collagen is type I collagen.

23. The porous electrospun graft material according to claim 1 , wherein the fibroin is silk fibroin.

24. The porous electrospun graft material according to claim 1 , wherein the hemocompatible synthetic elastomer is poly (glycerol sebacate).

25. The porous electrospun graft material according to claim 1 , further comprising an electronegative carbohydrate.

26. The porous electrospun graft material of claim 25 , wherein the electronegative carbohydrate comprises a glycosaminoglycan, a growth factor, a cell signaling molecule, or a combination thereof.

27. A graft for heart valve replacement, comprising the porous electrospun graft material of claim 1 .

28. The graft of claim 27 , wherein the poly glycerol derivative is poly (glycerol sebacate).

29. A porous electrospun graft material configured to replace biological tissue, wherein the porous electrospun graft material comprises collagen: fibroin: poly (glycerol sebacate) at 4.5:4.5:1 weight ratio.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2015
From: WAGNER, WILLIAM D.; POLYACHENKO, NICOLE LEVI-; WANG, RUI; ARGENTA, LOUIS C.; MORYKWAS, MICHAEL J.
To: WAKE FOREST UNIVERSITY HEALTH SCIENCES
Reel/Frame 035497/0611 →
Continuity (2)
Provisional Application 61718991 · Oct 26, 2012
Related Publication 20150272729A1 · Oct 1, 2015
Cited By (3)
US 12,186,187 US 12,343,256 US 12,588,993